Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Baiyunshan Pharma Expands Production Facility

publication date: Jul 7, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guangzhou Baiyunshan Pharma expanded its production facility in Jiexi county, Guangdong province to 1.1 million square meters. When fully used, the added capacity will bring in up to one billion RMB ($155 million) in additional revenues. Baiyunshan Pharma said the expansion will alleviate a capacity constraint on amoxicillin, the company's leading revenue producer. More details....

Stock Symbol: (SHE: 000522)

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...